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Abstract: Colorectal cancer is the abnormal growth of cells in colon or rectum. Recent find-
ings have acknowledged the role of bacterial infection and chronic inflammation in colorectal 
cancer initiation and progression. In order to detect and treat precancerous lesions, new tools 
are required, which may help to prevent or identify colorectal cancer at an early stage. To date, 
several different screening tests are available, including endoscopy, stool-based blood tests, 
and radiology-based tests. However, these analyses either lack sensitivity or are of an invasive 
nature. The use of fluorescently labeled probes can increase the detection sensitivity. However, 
autofluorescence, photobleaching, and photodamage are commonly encountered problems with 
fluorescence imaging. Upconverting nanoparticles (UCNPs) are recently developed lanthanide-
doped nanocrystals that can be used as light-triggered luminescent probes and in drug delivery 
systems. In this review, we comprehensively summarize the recent developments and address 
future prospects of UCNP-based applications for diagnostics and therapeutic approaches associ-
ated with intestinal infection and colorectal cancer.
Keywords: near infrared, imaging, bacteria, photodynamic therapy, anti-Stokes emission, 
inflammation
Introduction
Colorectal cancer is the third most common cancer worldwide and accounts for 
almost 10% of cancer-related deaths in Western countries.1 The growing evidence 
suggests that bacteria can play an important role in the initiation and progression of 
colorectal neoplasm by inducing chronic inflammation and by the release of carci-
nogenic metabolites.2 Some of the most commonly associated bacteria with colon 
cancer includes Fusobacteium nucleatum,3 Bacteroides fragilis, and Escherichia coli.4 
Inflammatory bowel disease (IBD)-associated colorectal cancer is a classic example 
of an inflammation-induced cancer form.5
Early detection of precancerous polyps can prevent the onset of colorectal neoplasm 
or increase the chances of a successful treatment. Currently, several different screening 
tests are available including endoscopy, stool-based blood tests, and radiology-based 
tests. However, these protocols lack either sensitivity or sufficient invasiveness, one 
of the reasons why colorectal cancer is still a major cause of cancer-related deaths 
in Western countries. The use of fluorescent labeling probes for cancer imaging 
increases the detection sensitivity. However, autofluorescence, photobleaching, and 
photodamage are the most commonly encountered problems with fluorescence imaging 
(FI). Recent reports have identified upconverting nanoparticles (UCNPs) as options 
to overcome these limitations.6,7 UCNPs are light-triggered lanthanide (Ln)-doped 
nanocrystals that can be used to detect and treat colorectal cancer and other intestinal 
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related pathologies, as depicted in Figure 1. UCNPs convert 
long-wavelength near infrared (NIR) excitation light into 
short-wavelength emission.8 At NIR, the nonspecific absorp-
tion and scattering of light by endogenous chromophores 
are at minimum.9 This leads to deeper penetration of light 
and high signal-to-noise ratio (SNR). Furthermore, with 
different modifications, UCNPs can be used to detect bac-
terial infection and inflammation, which appear to precede 
colorectal cancer.
In this review, we provide an updated summary and 
future prospects of UCNP-based applications in diagnos-
tics and therapeutics for intestinal infection and colorectal 
cancer.
Colorectal cancer
Cancer is defined as an uncontrolled cell proliferation induced 
by the accumulation of genetic or epigenetic mutations. 
Improvement in the average standard of living and basic 
health care facilities has considerably reduced the incidence 
of communicable diseases. These advances have led to an 
increase in average life expectancy in almost every region of 
the world. Although the incidence of communicable diseases 
is decreased as a result of improved medical facilities, cancer 
mortality rates have increased by almost 40% in the last few 
decades. Cancer diagnoses increased by 33% between 2005 
and 2015, and in 2015, over 8.7 million people globally have 
died due to cancer. It is projected that the number is expected 
to reach 13 million people by 2030.1 Colorectal cancer is 
the second most common form of cancer in women and the 
third most common in men, and globally, it is the third most 
common cancer, with 1.4 million new cases diagnosed in 
2012 alone.10
Both genetic and environmental factors play a role in the 
etiology of colorectal cancer. Patients affected by hereditary 
colorectal cancer syndrome accounts for 5%–10% of reported 
colorectal cancer cases. Among these, Lynch syndrome, 
which is caused by a mutation in the DNA mismatch-repair 
genes, such as EPCAM, PMS2, MLH1, MLH2, and MLH6, 
is the most common cancer syndrome.11,12 Familial adeno-
matous polyposis is the second most common hereditary 
syndrome, which is caused by a mutation in the adenomatous 
polyposis coli (APC), a component of the Wnt-signaling 
pathway.12 Furthermore, lifestyle factors such as smoking,13 
alcohol consumption,14 and high body mass index15 may 
lead to an increase risk of colorectal cancer development. 
To a certain extent, these lifestyle factors can explain the 
geographical and socioeconomic distribution of colorectal 
cases.16
In the last decade, it has become evident that the inflam-
matory microenvironment is essential for tumor development 
and progression. Hallmarks of cancer-inducing inflammation 
include the presence of inflammatory cells, inflammatory 
mediators such as cytokines and chemokines, tissue repair 
and remodeling, and fibrosis.17 Inflammation is the key 
component of the host immune system’s fight against foreign 
invaders such as bacteria and viruses. Acute inflammation, 
if resolved properly, results in the tissue repair and healing 
and maintenance of homeostasis. However, uncontrolled 
chronic inflammation may lead to malignancy. Notably, 
patients with early-onset IBD develop long-term chronic 
Figure 1 In vivo applications of UCNPs in intestinal infection, inflammation, and colorectal cancer.
Notes: In this figure, we depict potential (red arrows) and current (blue arrow) target areas where UCNPs can be used either for imaging or treating infection, inflammation, 
and colon cancer. Bacterial infection and/or inflammation leading to IBD and colorectal cancer are depicted with black arrows. UCNPs loaded with antimicrobial and anti-
inflammatory compounds can be used to treat infection, inflammation, and cancer. Furthermore, hypoxia-sensitive UCNPs can be used to monitor the hypoxic state of the 
gastrointestinal tract. Due to the NIR excitation range, UCNPs are currently being used for localized PDT in certain cancer forms.
Abbreviations: IBD, inflammatory bowel disease; NIR, near infrared; PDT, photodynamic therapy; UCNPs, upconverting nanoparticles.
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intestinal inflammation and, therefore, present an increased 
risk of developing colon cancer.18
Bacteria and colorectal cancer
The intestinal tract acts as a reservoir for various microbial 
species, collectively known as the intestinal microbiota.19 In 
the last two decades, accumulating evidence has indicated 
that the gut microbiota plays a critical role in providing nutri-
ents to the gut mucosa, in the development of the mucosal 
immune system, and in preventing pathogen colonization.20 
The mucosal immune system’s main tasks are to mount 
an immune response against pathogenic microbes and to 
maintain tolerance against food and commensal microbial 
antigens. Loss of tolerance to commensal enteric microorgan-
isms ultimately leads to uncontrolled chronic inflammation 
exemplified by that seen in patients with IBD. In addition, 
since the colon carries 1012 bacteria/mL, compared to 102 bac-
teria/mL in the small intestine, the colon presents a 12-fold 
higher risk of developing tumors.21 Indeed, recent findings 
suggest that microbes such as F. nucleatum,22 enterotoxi-
genic B. fragilis, Streptococcus bovis, E. coli, and Klebsiella 
pneumoniae can play an important role in colon cancer 
development.23,24 These gut-associated bacteria can increase 
the risk of tumor malignancy by several mechanisms includ-
ing mutagenesis, secretion of mutagenetic metabolites, and 
the risk of promoting inflammation. Lately, a link between 
gut bacteria and the efficacy of anti-PD-1 immunotherapy 
has also been uncovered.25–27 Collectively, these studies 
establish an important link between bacteria and colorectal 
cancer pathogenesis.
Upconverting nanoparticles
As stated previously, development of new tools to image 
or even treat diseases such as colon cancer are required. 
Among these, UCNPs have been shown to have advanta-
geous properties compared to other available probes. UCNPs 
are a unique class of photoluminescent materials capable of 
exploiting photon upconversion (UC).28 Two or multiple 
excitation photons with lower energy are converted into 
one emitted photon with higher energy. In general, NIR 
light is converted into ultraviolet (UV), visible (VIS), and 
anti-Stokes shifted NIR light.29 A typical luminescent UCNP 
consists of an inorganic host crystal and doped Ln3+ ions 
used as sensitizers and activators, as illustrated in Figure 2A. 
Numerous UC mechanisms in Ln-doped crystals were rec-
ognized and formulated including excited-state absorption, 
energy transfer UC (ETU), photo avalanche, cooperative 
sensitization UC, and cross-relaxation.30,31 Among all of these 
processes, ETU has the highest two-photon UC efficiency.30 
In a typical ETU process, a sensitizer ion sequentially absorbs 
incoming photons by donating its energy at its excited state 
to an activator ion. Through the sequential energy transfers 
Figure 2 UCNP characteristics.
Notes: (A) A cross-sectional schematic representation of a typical UCNP. This includes an optically inert host crystal where optically active Ln3+ activator and sensitizer 
ions are embedded by replacing the cations of host matrix in the crystallization process. (B) Lanthanide-based UCNPs in colloidal solution are able to convert NIR light 
into different wavelengths in the VIS region of the EM. Reproduced from Zhong Y, Tian G, Gu Z, et al. Elimination of Photon Quenching by a Transition Layer to Fabricate 
a Quenching-Shield Sandwich Structure for 800 nm Excited Upconversion Luminescence of Nd3+-Sensitized Nanoparticles. Adv Mater. 2013;26(18):2831–2837.29 Publisher: 
John Wiley and Sons. © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. (C) Ln3+ ions exhibit different emission spectral bands under NIR excitation, spanning 
from NIR to VIS and UV regions as each Ln3+ has its unique energy level structure.
Abbreviations: eM, electromagnetic; NIR, near infrared; UCNP, upconverting nanoparticle; Uv, ultraviolet; vIS, visible.
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from the sensitizers, the activator ion undergoes multi-step 
excitation, which results in UC luminescence.
To date, several different crystal compositions have been 
investigated as host crystals, including oxides, fluorides, 
vanadates, sulfides, and chlorides.32–37 Among the reported 
host crystals, fluoride-based NaREF
4
 crystals (in particular 
NaYF
4
) are the most favorable host materials due to their low 
photon energy and high chemical stability.38,39 Lns, a special 
group of elements in the periodic table, offer unique energy 
level structure, which are beneficial for use in UCNP. UCNPs 
embedded with Ln3+ ions produce sharp emission spectral 
peaks varying from UV to NIR region of electromagnetic 
(EM) spectrum, as shown in Figure 2B.29
Among all Lns, trivalent thulium (Tm3+), erbium (Er3+), 
and holmium (Ho3+) are the most favorable activators used 
as luminescent centers due to their higher UC emission effi-
ciency when they are doped with trivalent ytterbium (Yb3+), 
an efficient NIR sensitizer. Another commonly used sensi-
tizer is trivalent neodymium (Nd3+) ion, which has relatively 
high molar extinction coefficient in the NIR region. Due to 
the unique energy level structure of each Ln3+ ion, UC emis-
sion wavelength is dependent on the type of Ln3+ ion used 
as an activator ion.40 Typical activator Ln3+ ions with their 
observed UC emission wavelengths in the EM are shown 
in Figure 2C. Moreover, UC emission varies depending on 
the host crystal type, concentration ratio between activa-
tor and sensitizer dopants, and the crystalline phase of the 
nanocrystal. 40–42
Inexpensive low power continuous wave NIR light 
sources are adequate to generate UC emission in Ln-based 
UCNPs. NIR excitation of UCNPs enables deeper tissue 
penetration.43,44 Most of the intrinsic tissue biomolecules are 
relatively weak scatters and absorbers in the NIR region.45 
Thus, tissue autofluorescence is minimized, which yields 
superior sensitivity and higher SNR. Furthermore, narrow 
emission bandwidths of Ln3+ ions originating from the 
electronic transitions within 4f energy states have relatively 
long emission lifetime ranging from microseconds to mil-
liseconds.46 Unlike quantum dots (QDs), another class of 
photoluminescent materials, Ln-based UCNPs do not display 
photoblinking and UC emission wavelength is not susceptible 
to changes in particle size47 – thus long-term continuous 
imaging is feasible. Moreover, Ln-based UCNPs do not 
suffer from photobleaching and offer high photochemical 
stability as compared to conventional organic fluorophores 
and QDs.48
Although UCNPs with their unique optical properties 
offer numerous advantages in bioimaging, an ideal Ln-based 
UCNP also requires various physical and chemical criteria 
for efficient use in biological applications. Hydrophilicity and 
high colloidal stability are critical functionalities. Function-
alization of UCNPs surface is crucial for further interaction 
with various bio-entities. The introduction of functional 
groups such as carboxyl (-COOH), thiol (-SH), hydroxyl 
(-OH), maleimide (MA), amine (-NH), and amino (-NH
2
) 
to the surface of UCNPs provides capabilities for covalent 
attachment and bio-conjugation with a variety of biomol-
ecules including proteins, antibodies, oligonucleotides, and 
cell receptors.49
There are still some hurdles to overcome to allow a wider 
use of UCNPs. For example, quantum yield (QY), a param-
eter proportional to brightness, is relatively low, particularly 
at the low optical power regime that is required to avoid any 
photodamage to biological specimens. The UC QYs of dif-
ferent kinds of UCNPs are summarized deftly by Wilhelm.50 
In addition, although no or some toxicity of UCNPs has been 
reported in rodents,51,52 no reports in human studies are yet 
available and there are still no adequate research studies to 
evaluate the biodistribution of UCNPs in vivo in humans.53 
In addition, nonspecific accumulation of UCNPs in reticu-
loendothelial system including liver and spleen is still a big 
hurdle in the field.54
Surface modification of UCNPs for 
biological applications
There are a number of methods to synthesize UCNPs, includ-
ing co-precipitation, thermal decomposition, hydro(solvo)
thermal, and microwave-assisted synthesis, all of which 
have been reviewed in details in various articles.55–58 In 
general, hydrophobic ligands, oleylamine or oleic acid, are 
favored during the synthesis of UCNPs to control the crystal 
growth, phase, shape, and size, in order to yield high-quality 
monodispersed UCNPs with uniform size and shape. These 
hydrophobic ligands form a layer upon the surface of UCNPs, 
hence they become dispersible in nonpolar organic solvents 
such as hexane and toluene. However, UCNPs capped with 
hydrophobic surfactant molecules lack biocompatibility. 
They cannot be utilized directly in biomedical applications, 
as they cannot disperse in water.
Biocompatibility of UCNPs in vivo and in vitro is gov-
erned by their surface properties. Fortunately, the surface 
nature of Ln-based UCNPs can be changed by the following 
surface modification approaches. Ligand interaction, ligand 
oxidization, layer-by-layer deposition, and ligand exchange 
are the most common strategies to alter the surface charac-
teristics of UCNPs59 and result in the gain of hydrophilic 
characteristics by hydrophobic UCNPs. Moreover, as a 
consequence of these modifications, the surface of UCNPs 
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
3.
23
9.
10
2.
11
7 
on
 1
2-
Ju
n-
20
19
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2019:14 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1031
Singh et al
hosts functional groups, which enables conjugation with 
other biomolecules such as antibodies.
UCNPs functionalized with carboxylic acid group are 
particularly suitable for conjugating with biomolecules con-
taining amine group through covalent linkage. Kumar et al60 
demonstrated the conjugation of mercaptopropionic acid-
capped NaYF
4
:Gd3+, Yb3+, Er3+ UCNPs with anti-claudin-4 
antibody for imaging cancer cells. Similarly, the amine group 
present on the UCNPs’ surface can bind to molecules contain-
ing the carboxylic group. Zhan et al61 successfully targeted 
carcinoembryonic antigen (CEA) on the surface of HeLa 
cells in vitro by employing polyallylamine hydrochloride-
coated mercaptosuccinic acid-capped NaYbF
4
:Yb3+, Ho3+ 
and NaYbF
4
:Yb3+, Tm3+ UCNPs immunolabeled with anti-
CEA8 antibodies.
Furthermore, Raphaela et al reported that MA-functional-
ized PEG-UCNPs can conjugate with γ-globulin via thioether 
linkage.62 Also, Xiong et al63 reported the binding of MA 
group to amine-capped NaYF
4
:Yb3+, Er3+ (Tm3+) UCNPs. In 
addition, Feng et al64 reported a method to synthesize chito-
san-capped LaF
3
:Eu3+, which is water soluble and contains 
hydroxyl and amine groups. Additionally, Li et al65 modified 
the surface of hydrophobic OM-capped NaYF
4
:Yb3+, Er3+ by 
using thioglycollic acid (TGA), which results in hydrophilic 
UCNPs containing carboxyl and thiol groups.
Therefore, surface modifications play a crucial role to 
resolve biocompatibility issues arising from conventional 
synthesis methods of UCNPs. As a consequence of appropri-
ate modifications, UCNPs can gain new surface properties, 
such as hydrophilicity, biocompatibility, colloidal stability, 
and bio-targeting, which are crucial for UCNPs to be more 
extensively used in biological applications.
Optical imaging (OI)
Molecular imaging plays a significant role in medicine, pro-
viding essential diagnostic and prognostic information of a 
disease by the visualization and characterization of biological 
processes at cellular and/or subcellular levels. The benefit of 
molecular imaging techniques is the evaluation of molecular 
changes rather than morphological abnormalities.
OI is a rapidly emerging molecular imaging method 
where light–tissue interactions such as absorption, scat-
tering, and fluorescence are investigated. Due to the 
cost-effectiveness and simplicity, FI has been a method of 
choice for biological researchers. This technique relies on 
the endogenous or exogenous fluorescent characteristics of 
biomolecules. A fluorescent biomolecule is able to absorb 
excitation light at different wavelengths, with varying 
strengths, and re-emit light at a longer wavelength than 
that of the excitation light, which is known as fluorescence 
emission. The biomolecules with this ability are considered 
as promising molecular contrast agents for in vivo and in 
vitro applications. However, endogenous contrast agents 
generally exhibit inadequate spectroscopic characteristics. 
Therefore, exogenous fluorescent contrast agents includ-
ing organic dyes (eg, indocyanine green [ICG], fluorescein 
sodium, and methylene blue), fluorescent proteins (eg, green 
fluorescent protein), and QDs (eg, CdSe
2
, Ag
2
, and CuInS
2
) 
are externally administered to enhance image contrast. 
Despite the remarkable optical properties of the exogenous 
fluorescent contrast agents, their use in molecular imaging 
is limited. This is due to several reasons. First, they suffer 
from relatively poor spatial resolution due to the overlap 
of excitation and fluorescence emission spectra of major 
fluorescent tissue components (eg, nicotinamide adenine 
dinucleotide, collagen, elastin, and flavins), ie, tissue auto-
fluorescence. Second, exogenous fluorescent contrast agents 
generally require UV or VIS light excitation, which limits 
the light penetration depth due to a relatively high absorption 
and scattering nature of bio-entities inside the tissue. Hence, 
deep tissue imaging with high sensitivity becomes difficult. 
While employing QDs, cytotoxicity appears a major chal-
lenge due to the presence of toxic heavy metals commonly 
used including cadmium, silver, and copper. They also 
exhibit photoblinking effects upon continuous irradiation, 
which hinders long-term imaging. Moreover, organic dyes 
and fluorescent proteins suffer from photobleaching effect; 
the fluorescence emission fades after relatively short time as 
the molecule starts to degrade under continuous irradiation, 
which also impedes long-term imaging. To date, among 
all reported exogenous fluorescent contrast agents, only 
two NIR fluorescent molecules, ICG and IRDye800CW 
conjugate, are approved by Food and Drug Administration 
(FDA).66 Noura et al showed the feasibility of a lateral region 
sentinel node biopsy of lower colorectal rectal cancer guided 
by ICG.67 Additionally, Gong et al68 used IRDye800CW to 
image the tumors in colorectal cancer.
Considering the aforementioned issues associated with 
the existing fluorescent contrast agents, Ln-based UCNPs 
with their previously stated remarkable optical features can be 
considered as promising photoluminescent contrast markers. 
Ln-based UCNPs with their NIR excitation ability can avail 
of optical transparency window, thus maximizing high light 
penetration depths. In addition, their photon UC ability gives 
them anti-Stokes shifted characteristics, which minimizes 
tissue autofluorescence. As they show high photochemical 
stability, they do not create photoblinking and photobleaching 
effects under long-term continuous irradiance.
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In the next sections, we will be focusing on UCNPs’ 
applications of bacterial, anti-microbial detection as well as 
tumor imaging.
Bacterial detection using UCNPs
The well-known bacterial detection techniques, culture-
based or DNA-based using PCR, present both benefits and 
deficiencies. Various drawbacks in these methodologies, 
which make them less suitable for on-site diagnosis, include 
enrichment steps and inability to simultaneously detect two 
or more bacteria or amplification steps, which makes pro-
cess more time-consuming.69 Recently, bacterial detection 
using UCNPs (Table 1 and Figure 3A) has been shown to 
be successful by improving the sensitivity and the speed of 
the detection process.
Ong et al reported the first in vitro study showing that 
UCNPs coupled with an anti-E. coli antibody successfully 
detected E. coli as a consequence of superior photostability 
of the UCNP-labeled bacteria as compared to the GFP-
expressing bacteria.70 Moreover, using a dendritic cell and 
bacteria co-culture infection system, the potential of UCNPs’ 
imaging for long-term bacterial trafficking was also dem-
onstrated. Additionally, Pan et al71 were able to reduce the 
detection level of E. coli as low as 10 CFU/mL, when using 
UCNPs functionalized with an anti-E. coli antibody. In an 
in vitro study, Wu et al,69 improved the existing technology 
using multicolor UCNPs, doped in various rare-earth metals 
to obtain different emission peaks, coupled with bacteria-spe-
cific aptamers, and confirmed simultaneous detection of three 
different bacterial strains, such as Staphylococcus aureus, 
Vibrio parahemolyticus, and Salmonella typhimurium. The 
authors also tested if their UCNPs’ conjugates were able 
to detect the three bacteria in real food samples, providing 
evidence for the potential use of UCNPs in bioassays for food 
safety. Dai et al72 also measured the level of ochratoxin, a 
group of mutagenic and teratogenic compounds produced by 
Aspergillus and Penicillium fungal species, in beer samples 
by using UCNPs–aptamer complexes. More recently, the 
periodontal pathogen Porphyromonas gingivalis was also 
detected by UCNPs and, similar to E. coli studies, the P. 
gingivalis detection limit was 10 CFU/mL.73 Furthermore, 
Cheng et al designed a luminescence energy transfer system, 
where anti-Salmonella aptamer-conjugated UCNPs served as 
energy donor and gold nanorods served as acceptor allow-
ing the detection of Salmonella in an aqueous buffer with a 
detection limit of 11 CFU/mL. In the absence of Salmonella, 
the electrostatic interaction between the negatively charged 
UCNPs and the positively charged gold particles shorten 
the distances between these two, leading to luminescence 
quenching. However, addition of Salmonella into the  system 
Table 1 List of published studies where UCNPs were used to detect bacteria
Type of UCNPs’ system used UCNPs’ 
conjugation
Bacteria/bacterial 
metabolite detected
Advantage Reference
Multicolor UCNPs
(NaYF4:Yb, Tm
NaYF4:Yb, Ho
NaYF4:Yb, Er/Mn)
Antibacteria 
aptamer
S. aureus, Vibrio 
parahemolyticus, and 
S. typhimurium
High specificity, 
simultaneous detection
wu et al69
NaYF4:Yb, er Anti-E. coli 
antibody
E. coli High photostability Ong et al70
NaYF4:Yb, er Anti-E. coli 
antibody
E. coli Low detection 
limit – 10 CFU/mL
Pan et al71
NaYF4:Yb0.2, Tm0.02 Anti-ochratoxin 
A aptamer
Ochratoxin A High sensitivity Dai et al72
NaYF4:Tm@SiO2, NaYF4:er@SiO2 Anti-P. gingivalis 
antibody
P. gingivalis Low detection 
limit – 10 CFU/mL
Qin et al73
LET, Mn2+-doped NaYF4:Yb, Tm as donor and Au 
nanorod as acceptor
Anti-Salmonella 
aptamer
S. typhimurium Low detection 
limit – 11 CFU/mL
Cheng et al74
FReT, Au NP as donor and NaYF4:Yb/er as acceptor Antiaptamer 
cDNA
E. coli, B. subtilis, and 
S. aureus
Detect E. coli in real 
food and water samples
Jin et al75
Optical trapping, KLu2F7:Yb3+, er3+ None E. coli Single bacteria detection Xin et al76
Bio-microlens to enhance the upconversion 
fluorescence of NaYF4:Yb3+/Tm3+
None E. coli Single bacteria detection Li et al77
Abbreviations: B. subtilis, Bacillus subtilis; E. coli, Escherichia coli; FRET, fluorescence resonance energy transfer; LET, luminescence energy transfer; NP, nanoparticle; 
P. gingivalis, Porphyromonas gingivalis; S. aureus, Staphylococcus aureus; S. typhimurium, Salmonella typhimurium; UCNPs, upconverting nanoparticles.
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restores the luminescence by increasing the distance between 
the donor and the acceptor due to the binding of Salmonella 
to the UCNPs through anti-Salmonella aptamer.74 Jin et al75 
also developed a similar fluorescence resonance energy 
transfer (FRET) system by using gold nanoparticle aptam-
ers as the donor and UCNPs coupled with cDNA as the 
acceptor. Recently, Xin et al76 and Li et al77 reported that 
a single bacteria resolution was achieved by enhancing the 
UC fluorescence of UCNPs using the trapped optical fiber on 
yeast and human cells, respectively, as form of a microlens. 
These collective data demonstrate that UCNPs can be used 
as a luminescent probe to detect bacterial signal as low as 
1 CFU, which can be of relevance for a number of different 
areas including diagnostics and food industry.
Antimicrobial applications of UCNPs
As illustrated in Figure 3, the use of UCNPs has not only 
been limited to bacterial detection. For example, NIR-trig-
gered release of the antibiofilm agent d-amino acid and other 
bactericides was used to eradicate bacteria and biofilms.78 
UCNPs coated with a thin layer of TiO
2
, with an emission 
frequency in the UV region, is linked to d-amino acid 
through a UV cleavable linkage. Upon excitation at NIR, 
UCNPs emit photons in UV range, which subsequently lead 
????????????????????
???? ???????????????
??
????
????
????????
????????
???????????????
?
??????????????
Figure 3 Mode of action of UCNPs in visualizing and killing bacteria.
Notes: In this figure, we summarize published work on UCNPs’ role in visualizing and killing bacteria. (A) Functionalized UCNPs targeting bacteria with NIR/VIS emission 
range is used to image the bacteria. (B) UCNPs loaded with antimicrobial compounds or with an UV emission range are used for localized antimicrobial activity.
Abbreviations: NIR, near infrared; UCNPs, upconverting nanoparticles; Uv, ultraviolet; vIS, visible.
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to the controlled release of ROS from TiO
2
 and d-amino 
acid. Furthermore, Li et al79 developed a FRET system 
using UCNPs as energy donors and poly[9,9-bis(6,6-
(N,N,N-trimethylaminium)-fluorene-2,7-ylenevinylene)-
co-alt-2,5-dicyano-1,4-phenylene] (PFVCN), a conjugate 
polymer (CP), as energy acceptor. CPs are organic polymers 
that have emerged as alternative antibiotics and therefore 
can led to the generation of ROS by absorbing UV or VIS 
light. However, UV light in itself can damage the cells and 
VIS light is too weak to penetrate deeper into the tissue. To 
overcome these limitations, the authors used the UCNPs/
PFVCN FRET system. In this system, UCNPs convert the 
NIR light into localized UV light, which is subsequently 
absorbed by PFVCN and generates ROS. In addition, to kill 
multidrug-resistant S. aureus and β-lactamase-producing 
E. coli, a photodynamic system, where UCNPs were 
coated with N-octyl chitosan loaded with ROS producing 
zinc phthalocyanine as photosentsitizer, was developed.80 
Collectively, these reports highlight further the use for 
UCNPs as a light-triggered antimicrobial agent (Table 2 and 
Figure 3B), which could potentially replace conventional 
antimicrobial drugs.81
Detection and treatment of colon cancer 
by UCNPs
Due to the low fluorescence background in the NIR region, 
NIR fluorescent nanoparticles and dyes in conjugation with 
tumor-targeting ligands have been preferentially used for 
in vivo imaging of colorectal cancer (Table 3). However, 
commonly encountered issues with dyes or other lumines-
cent materials include low penetration depth, photobleach-
ing, autofluorescence, and high background signal. To 
overcome these limitations, tumor-targeting UCNPs have 
been developed (Table 3). The feasibility of UCNPs to act 
as a contrasting agent was initially reported by Liu et al82 
who successfully imaged the mouse gastrointestinal tract 
using UCNPs. Next, tumor-targeting UCNPs were devel-
oped with the aim to detect primary gastric tumors and 
lymphatic metastasis using an orthotopic tumor model.83 
Biocompatible tumor targeting UCNPs were used to detect 
primary colorectal cancer in Kunming mice.84 To date, 
UCNPs are commonly administered intravenously for 
colorectal imaging in mice. However, a study by Gao et al85 
comparing biodistribution and accumulation of UCNPs 
in cancerous and normal tissues demonstrated that intra-
peritoneal administration of UCNPs in a colorectal cancer 
model appeared to be a superior route when compared with 
intravenous administration.
Recently, UCNPs loaded with an immune adjuvant, a 
toll-like receptor-7 agonist were used with the FDA-approved 
check-point inhibitor anti-cytotoxic T lymphocyte-associated 
protein 4 antibody to treat a primary tumor in an animal 
model of colorectal cancer.86 NIR exposure triggers photo-
dynamic destruction of the primary tumor. Subsequently to 
photodynamic therapy (PDT), the cancer-associated antigens 
released from the cancerous tissue induce an anticancer 
immune response with the help of the immune adjuvant. 
The antitumor response is further potentiated by the check-
point inhibitor. 
The importance of the tumor microenvironment has 
been recently recognized as an attractive target for can-
cer treatment. Hypoxia, low pH, extracellular matrix, the 
tumor vascular system, immune cells, and tumor-associated 
fibroblasts collectively form the tumor microenvironment. 
UCNPs can be used to target the tumor microenvironment for 
therapeutic purposes. Indeed, a recent in vitro study reported 
a targeted killing of tumor cells by affecting specific tumor 
markers such as EGF by Ln-UCNPs.87 Overall, these find-
ings identify a potential use of UCNPs in colorectal cancer 
diagnosis and treatment.
Conclusion and future perspectives
In vitro and preclinical studies to date indicate that, for 
colorectal cancer, UCNPs are an enhanced and better imag-
ing strategy as compared with luminescent or fluorescence 
probes. Additional analyses have demonstrated that UCNPs 
can indeed target-specific bacteria strains and even exert 
antimicrobial actions upon NIR triggering, suggesting their 
Table 2 Antimicrobial actions of UCNPs
Type of UCNPs’ system used Antimicrobial Target bacterium Reference
β-NaYF4:Tm3+ coated with TiO2 d-amino acid (d-tyrosine) 
and ROS
Individual B. subtilis and biofilm wei et al78
β-NaYF4:Yb, Tm PFvCN E. coli Li et al79
Oleic acid capped β-NaYF4:23%Yb, 2%er@NaYF4 zinc 
phthalocyanine as photosensitizer
OC and ROS inducing zinc 
phthalocyanine
Multidrug-resistant S. aureus and 
β-lactamase-producing E. coli
Li et al80
Abbreviations: B. subtilis, Bacillus subtilis; E. coli, Escherichia coli; OC, N-octyl chitosan; PFVCN, poly(9,9-bis[6,6-{N,N,N-trimethylaminium}-fluorene]-2,7-ylenevinylene)-co-
alt-2,5-dicyano-1,4-phenylene]; S. aureus, Staphylococcus aureus; UCNPs, upconverting nanoparticles.
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utilities as new potential treatment strategies in colorectal 
cancer and other intestinal disorders.
The healthy gut maintains a state of hypoxia on and 
around the mucosal surface of the colon. However, in a 
chronically inflamed intestine (which often precedes a 
colorectal cancer finding in IBD patients), the concentra-
tion of oxygen on the colonic surface increases due to an 
increase in blood flow around the inflamed tissue. By utiliz-
ing a hypoxia-sensitive UCNPs’ imaging, the inflammatory 
state of the gut could be imaged with minimal invasiveness 
(Figure 1). Earlier identification of individuals predisposed 
to develop colorectal cancer or intestinal inflammation (eg, 
IBD) may result in better clinical outcomes.
Although several studies have demonstrated the involve-
ment of microbes in IBD and cancer progression, the mecha-
nistic insights into how these bacteria actually lead to these 
conditions or their potential role in relapse of disease are yet 
to be discovered. UCNPs can therefore be used to visual-
ize host–microbe interactions at the cellular and molecular 
levels to establish a cause and effect relationship for these 
chronic conditions.
Photodynamic therapy involves the generation of ROS 
resulting from the interaction of photosensitizer and VIS 
light. However, VIS light is too weak to penetrate deep into 
the tissue. Also, ROS production is limited due to the hypoxic 
environment of tumor and the colon tissue. Furthermore, 
ROS production consumes most of the oxygen available 
to an induced hypoxic environment in the tissue, which 
further potentiates tumorigenesis. Talaporifin sodium (TS), 
a light-activated drug/photosensitizer, has been approved in 
Japan for the treatment of early-state endobronchial cancer.88 
Activation of TS with a 664 nm VIS range light generates 
a single oxygen species, resulting in the induction of apop-
totic cell death.88 In a Phase II trial of TS in patients with 
colorectal cancer and metastasis to the liver, the efficacy of 
the treatment depended on the number of excitation sources 
used to activate the drug.89 This study shows that the treat-
ment efficacy depends on the penetration of cancer tissue 
by the excitation light with enough photons to activate the 
photosensitizer. UCNPs with emission at UV range could 
be used to overcome these limitations associated with VIS 
light and ROS production. Deep penetrating NIR light can 
be used to excite the UCNPs, and the localized emission of 
UV can be used to kill the surrounding carcinogenic cells.
However, even though NIR is nontoxic for biological tis-
sues, high intensity NIR can indeed overheat cells and result 
in photodamage90 of not only cancerous cells but also healthy 
and noncancerous cells. A way to reduce these issues is using T
ab
le
 3
 C
ol
or
ec
ta
l c
an
ce
r 
de
te
ct
io
n 
an
d 
tr
ea
tm
en
t 
us
in
g 
U
C
N
Ps
T
yp
e 
of
 U
C
N
P
s
U
C
N
P
s’
 c
on
ju
ga
ti
on
Li
ga
nd
 
sp
ec
ifi
ci
ty
T
um
or
 m
od
el
R
ou
te
 o
f 
U
C
N
P
s’
 
ad
m
in
is
tr
at
io
n
T
yp
e 
of
 t
um
or
 
de
te
ct
ed
A
nt
ic
an
ce
r 
pr
op
er
ty
 u
se
d
R
ef
er
en
ce
N
aG
dF
4:
Y
b,
 e
r@
N
aG
dF
4 
co
at
ed
 w
ith
 P
eG
FA
Fo
la
te
-r
ec
ep
to
r 
ov
er
ex
pr
es
si
ng
 
m
el
an
om
a 
ce
lls
C
he
m
ic
al
ly
 in
du
ce
d 
pr
im
ar
y 
co
lo
re
ct
al
 
ca
nc
er
 m
od
el
In
tr
av
en
ou
s 
in
je
ct
io
n
Pr
im
ar
y 
co
lo
re
ct
al
 
ca
nc
er
N
on
e
Li
u 
et
 a
l84
N
aL
uF
4:
Y
b,
 T
m
@
N
aL
uF
4 
na
no
cr
ys
ta
ls
 m
od
ifi
ed
 
w
ith
 c
itr
at
es
N
on
e
Pa
ss
iv
e 
ta
rg
et
in
g
K
un
m
in
g 
m
ic
e 
in
je
ct
ed
 
w
ith
 h
um
an
 c
ol
or
ec
ta
l 
ca
nc
er
 L
O
V
O
 c
el
l l
in
e
In
tr
ap
er
ito
ne
al
 
an
d 
in
tr
av
en
ou
s 
in
je
ct
ed
C
ol
or
ec
ta
l t
um
or
N
on
e
G
ao
 e
t 
al
85
Pe
G
yl
at
ed
 N
aY
F4
 
(Y
/Y
b/
Er
=
78
:2
0:
2)
C
e6
, a
 p
ho
to
se
ns
iti
ze
r,
 a
nd
 im
iq
ui
m
od
 
(R
83
7)
, a
 t
ol
l-l
ik
e-
re
ce
pt
or
-7
ag
on
is
t 
an
d 
an
 a
nt
i-C
T
LA
-4
, c
he
ck
po
in
t 
in
hi
bi
to
r
N
on
e
BA
LB
/c
 m
ic
e,
 
su
bc
ut
an
eo
us
ly
in
je
ct
ed
 C
T
26
 c
el
ls
In
tr
at
um
or
 
in
je
ct
io
n
C
ol
or
ec
ta
l t
um
or
PD
T
 w
ith
 
ch
ec
kp
oi
nt
 
in
hi
bi
to
r
X
u 
et
 a
l86
A
bb
re
vi
at
io
ns
: C
e6
, C
hl
or
in
 e
6;
 F
A
, f
ol
ic
 a
ci
d;
 P
D
T
, p
ho
to
dy
na
m
ic
 t
he
ra
py
; P
eG
, p
ol
ye
th
yl
en
e 
gl
yc
ol
.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
3.
23
9.
10
2.
11
7 
on
 1
2-
Ju
n-
20
19
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2019:14submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1036
Singh et al
800 nm excited Nd3+-based UCNPs, which leave cells intact 
due to less absorption of water90 or by lowering the laser 
power.91 In summary, we are confident that future studies 
will resolve the gap between the bench and clinical transla-
tion, resulting in the beneficial use of UCNPs in humans in 
several biological applications including diagnostics and 
treatment purposes.
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